Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
40
datasets available to search
ShareScore release 0.9.0
Dataset results
40 results for “radiation oncology”
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
ClinicalTrials.gov study NCT05943210. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
ClinicalTrials.gov study NCT05351294. IPD Sharing: NO. Countries: 1. Publications: 0.
Patient Experience Data in Radiation Oncology
ClinicalTrials.gov study NCT05224297. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effect of EMT on Anxiety Levels and Perception of Waiting Time in the Radiation Oncology Waiting Room
ClinicalTrials.gov study NCT03660319. IPD Sharing: NO. Countries: 1. Publications: 0.
SMC Radiation Oncology SABR Cohort for Oligometastasis
ClinicalTrials.gov study NCT07121335. IPD Sharing: NO. Countries: 1. Publications: 0.
Palliative Radiation Oncology Chief's Clinic
ClinicalTrials.gov study NCT03995927. IPD Sharing: NO. Countries: 1. Publications: 0.
ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology Treatment
ClinicalTrials.gov study NCT05787145. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Patient Registry for Radiation Oncology Techniques and Quality
ClinicalTrials.gov study NCT02368106. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
ClinicalTrials.gov study NCT02422550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial
ClinicalTrials.gov study NCT06974370. IPD Sharing: NO. Countries: 1. Publications: 0.
Validation Studies of Biomarkers for Precision Radiation Oncology in Locally Advanced Solid Tumors
ClinicalTrials.gov study NCT04110223. IPD Sharing: NO. Countries: 1. Publications: 0.
Comprehensive Digital Archive of Cancer Imaging-Radiation Oncology( CHAVI-RO )
ClinicalTrials.gov study NCT04249895. IPD Sharing: NO. Countries: 1. Publications: 0.
Three Fraction Radiation to Induce Immuno-Oncologic Response
ClinicalTrials.gov study NCT03978663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Oncology Patient Medical Physics Intervention Study
ClinicalTrials.gov study NCT04362306. IPD Sharing: NO. Countries: 1. Publications: 0.
Personal Health Train for Radiation Oncology in India and The Netherlands
ClinicalTrials.gov study NCT04655469. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Tobacco Use Intervention Among Radiation Oncology Patients
ClinicalTrials.gov study NCT00587353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Oncology
Radiation-treatment data from NCI-supported Cancer Centers and the Pediatric Proton/Photon Consortium Registry.
Simulated Radiotherapy Treatment Assisted With Pediatric Radiation Oncology With Movie Induced Sedation Effect Technique
ClinicalTrials.gov study NCT03556930. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dataset related to article "Re-irradiation for recurrent glioma: outcome evaluation, toxicity and prognostic factors assessment. A multicenter study of the Radiation Oncology Italian Association (AIRO)"
<p>Abstract</p> <p>INTRODUCTION:</p> <p>The prognosis of glioma is dismal, and almost all patients relapsed. At recurrence time, several treatment options are considered, but to date there is no a standard of care. The Neurooncology Study Group of the Italian Association of Radiation Oncology (AIRO) collected clinical data regarding a large series of recurrent glioma patients who underwent re-irradiation (re-RT) in Italy.</p> <p>METHODS:</p> <p>Data regarding 300 recurrent glioma patients treated from May 2002 to November 2017, were analyzed. All patients underwent re-RT. Surgical resection, followed by re-RT with concomitant and adjuvant chemotherapy was performed. Clinical outcome was evaluated by neurological examination and brain MRI performed, 1 month after radiation therapy and then every 3 months.</p> <p>RESULTS:</p> <p>Re-irradiation was performed at a median interval time (IT) of 16 months from the first RT. Surgical resection before re-RT was performed in 19% of patients, concomitant temozolomide (TMZ) in 16.3%, and maintenance chemotherapy in 29%. Total doses ranged from 9 Gy to 52.5 Gy, with a median biological effective dose of 43 Gy. The median, 1, 2 year OS were 9.7 months, 41% and 17.7%. Low grade glioma histology (p  ≪ 0.01), IT > 12 months (p = 0.001), KPS > 70 (p = 0.004), younger age (p = 0.001), high total doses delivered (p = 0.04), and combined treatment performed (p = 0.0008) were recorded as conditioning survival.</p> <p>CONCLUSION:</p> <p>our data underline re-RT as a safe and feasible treatment with limited rate of toxicity, and a combined ones as a better option for selected patients. The identification of a BED threshold able to obtain a greater benefit on OS, can help in designing future prospective studies.</p>
Dataset related to article "The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group "
<p>This record contains raw data related to article “The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group"</p> <p>Although systemic therapy represents the standard of care for polymetastatic kidney cancer, stereotactic body radiation therapy (SBRT) may play a relevant role in the oligometastatic setting. We conducted a multicenter study including oligometastatic kidney cancer treated with SBRT. We retrospectively analyzed 207 patients who underwent 245 SBRT treatments on 385 lesions, including 165 (42.9%) oligorecurrent (OR) and 220 (57.1%) oligoprogressive (OP) lesions. Most common sites were lung (30.9%) for OR group, and bone (32.7%) for OP group. Among 78 (31.8%) patients receiving concomitant systemic therapy, sunitinib (61.5%) and pazopanib (15.4%) were the most common for OR patients, while sunitinib (49.2%) and nivolumab (20.0%) for OP patients. End points were local control (LC), progression free survival (PFS), overall survival (OS), time to next systemic therapy (TTNS) and toxicity. Median follow-up was 18.6 months. 1, 2 and 3-year LC rates were 89.4%, 80.1% and 76.6% in OR patients, and 82.7%, 76.9% and 64.3% in those with OP, respectively. LC for OP group was influenced by clear cell histology (p = 0.000), total number of lesions (p = 0.004), systemic therapy during SBRT (p = 0.012), and SBRT dose (p = 0.012). Median PFS was 37.9 months. 1, 2- and 3-year OS was 92.7%, 86.4% and 81.8%, respectively. Median TTNS was 15.8 months for OR patients, and 13.9 months for OP patients. No grade 3 or higher toxicities were reported for both groups. SBRT may be considered an effective safe option in the multidisciplinary management of both OR and OP metastases from kidney cancer.</p> <p> </p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.